Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.78
-0.41 (-5.01%)
At close: Jan 15, 2026, 4:00 PM EST
7.86
+0.08 (1.02%)
After-hours: Jan 15, 2026, 7:56 PM EST
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,118,331
Profits / Employee
$358,976
Market Cap
1.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 952 | -591 | -38.30% |
| Dec 31, 2023 | 1,543 | -449 | -22.54% |
| Dec 31, 2022 | 1,992 | 451 | 29.27% |
| Dec 31, 2021 | 1,541 | 749 | 94.57% |
| Dec 31, 2020 | 792 | 624 | 371.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVAX News
- 23 hours ago - Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 8 days ago - Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 6 weeks ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 6 weeks ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 6 weeks ago - Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barrons
- 2 months ago - Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Shah Capital pushes for Novavax sale, warns of proxy fight - Reuters
- 2 months ago - Novavax to Participate in Jefferies London Healthcare Conference - PRNewsWire